Search Results - "Resovi, Andrea"
-
1
Soluble stroma‐related biomarkers of pancreatic cancer
Published in EMBO molecular medicine (01-08-2018)“…The clinical management of pancreatic ductal adenocarcinoma (PDAC) is hampered by the lack of reliable biomarkers. This study investigated the value of soluble…”
Get full text
Journal Article -
2
Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth
Published in Journal of experimental & clinical cancer research (09-08-2023)“…The pancreatic microenvironment has a defensive role against cancer but it can acquire tumor-promoting properties triggered by multiple mechanisms including…”
Get full text
Journal Article -
3
CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with Chemotherapy
Published in Cells (Basel, Switzerland) (13-04-2020)“…The prominent desmoplastic stroma of pancreatic ductal adenocarcinoma (PDAC) is a determinant factor in tumor progression and a major barrier to the access of…”
Get full text
Journal Article -
4
Inhibition of SIRT2 Potentiates the Anti-motility Activity of Taxanes: Implications for Antineoplastic Combination Therapies
Published in Neoplasia (New York, N.Y.) (01-09-2012)“…Abstract Taxanes are potent inhibitors of cell motility, a property implicated in their antiangiogenic and antimetastatic activity and unrelated to their…”
Get full text
Journal Article -
5
Thrombospondin-1 promotes mesenchymal stromal cell functions via TGFβ and in cooperation with PDGF
Published in Matrix biology (01-09-2016)“…Mesenchymal stromal cells (MSC) are characterized by unique tropism for wounded tissues, high differentiating capacity, ability to induce tissue repair, and…”
Get full text
Journal Article -
6
Current understanding of the thrombospondin-1 interactome
Published in Matrix biology (01-07-2014)“…The multifaceted action of thrombospondin-1 (TSP-1) depends on its ability to physically interact with different ligands, including structural components of…”
Get full text
Journal Article -
7
Abstract 198: The T3R domain of thrombospondin-1 delays tumor growth and improves tumor response to chemotherapy by remodeling the tumor vasculature
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract The disorganized and inefficient nature of the tumor vasculature affects the delivery and activity of antineoplastic treatments. Certain…”
Get full text
Journal Article -
8
Thrombospondin-1 promotes mesenchymal stromal cell functions via TGFß and in cooperation with PDGF
Published in Matrix biology (01-09-2016)“…Mesenchymal stromal cells (MSC) are characterized by unique tropism for wounded tissues, high differentiating capacity, ability to induce tissue repair, and…”
Get full text
Journal Article -
9
Tumor vascular remodeling by thrombospondin-1 enhances drug delivery and antineoplastic activity
Published in Matrix biology (01-09-2021)“…•The abnormal morphological and functional properties of the tumor vasculature are a major hindrance to the distribution and efficacy of antineoplastic…”
Get full text
Journal Article -
10
Targeting angiogenesis with compounds from the extracellular matrix
Published in The international journal of biochemistry & cell biology (01-12-2011)“…The extracellular matrix (ECM) is the central element of a pericellular network of bioactive molecules. It orchestrates molecular interactions, availability…”
Get full text
Journal Article -
11
Abstract 2981: Identification of circulating stroma-related biomarkers for pancreatic ductal adenocarcinoma
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive epithelial malignancies characterized by a relevant amount of tumor stroma. It…”
Get full text
Journal Article -
12
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors
Published in Scientific reports (22-03-2016)“…The FGFs/FGFRs system is a recognized actionable target for therapeutic approaches aimed at inhibiting tumor growth, angiogenesis, metastasis, and resistance…”
Get full text
Journal Article -
13
Apelin Resistance Contributes to Muscle Loss during Cancer Cachexia in Mice
Published in Cancers (02-04-2022)“…Cancer cachexia consists of dramatic body weight loss with rapid muscle depletion due to imbalanced protein homeostasis. We found that the mRNA levels of…”
Get full text
Journal Article -
14
Abstract B12: Circulating stroma-related molecules as potential biomarkers for pancreatic ductal adenocarcinoma
Published in Cancer research (Chicago, Ill.) (01-07-2015)“…Abstract Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with limited treatment options. Early diagnostic serological markers capable of…”
Get full text
Journal Article -
15
Abstract 3857: Patient-derived tumor xenografts as pharmacological model of human pancreatic ductal adenocarcinoma
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract INTRODUCTION and AIM Pancreatic ductal adenocarcinoma is a lethal disease with an overall survival rate of 5% and a median survival time of less than…”
Get full text
Journal Article -
16
Trabectedin and Lurbinectedin Extend Survival of Mice Bearing C26 Colon Adenocarcinoma, without Affecting Tumor Growth or Cachexia
Published in Cancers (17-08-2020)“…Trabectedin (ET743) and lurbinectedin (PM01183) limit the production of inflammatory cytokines that are elevated during cancer cachexia. Mice carrying C26…”
Get full text
Journal Article -
17
Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts
Published in Connective tissue research (03-09-2015)“…Thrombospondin-1 (TSP-1), a major regulator of cell interaction with the environment, is often deregulated in cancers, including ovarian carcinoma. Both the…”
Get more information
Journal Article -
18
Inhibition of SIRT2 Potentiates the Anti-motility Activity of Taxanes: Implications for Antineoplastic Combination Therapies12
Published in Neoplasia (New York, N.Y.) (01-09-2012)“…Taxanes are potent inhibitors of cell motility, a property implicated in their antiangiogenic and antimetastatic activity and unrelated to their…”
Get full text
Journal Article